« Previous
Next »
The Journal of Arthroplasty
Volume 18, Issue 3
, Pages 352-360
, April 2003
The application potential of sintered β-dicalcium pyrophosphate in total joint arthroplasty
References
-
.
Calcium phosphates as ceramics as hard tissue prosthetics.
Clin Orthop. 1981;157:259
- . Use of porous hydroxyapatite blocks for augmentation of atrophic mandibles. J Oral Maxillofac Surg. 1988;46:533
- . Bioceramics: material characteristics versus in vivo behavior. J Biomed Mater Res. 1987;21(Suppl A2):219
- Mechanical properties and histological evaluation of sintered beta-Ca2P2O7 with Na4P2O7•10H2O addition. Biomaterials. 1995;16:793
- Prevascularized bone graft cultured in sintered porous beta-Ca2P2O7 with 5 wt% Na4P2O7•10H2O addition ceramic chamber. Biomaterials. 1996;17:1133
- . Reactions of the articular capsule to wear products of artificial prosthesis. J Biomed Mater Res. 1977;11:157
- . Cell damage in vitro following direct contact with fine particles of titanium, titanium alloy and cobalt-chrome-molybdenum alloy. Biomaterials. 1994;15:713
- The effects of calcium phosphates particles on the growth of osteoblast. J Biomed Mater Res. 1997;37:324
- The influence of hydroxyapatite particles on osteoclasts cell activities. J Biomed Mater Res. 1999;45:311
- Macrophage coclony-stimulating factor is indepensable for both proliferation and differentiation of osteoclast progenitors. J Clin Invest. 1993;91:257
- Osteoblastic cells are involved in osteoclast formation. Endocrinology. 1988;123:2600
- The influence of hydroxyapatite particle size on bone cell activities: an in vitro study. J Biomed Mater Res. 1998;39:390
- Immune response of rats to frozen bone allografts. J Bone Joint Surg Am. 1983;65:239
-
.
Biodegradable bone repair materials: synthetic polymers and ceramics.
Clin Orthop. 1986;207:290
- . The use of frozen cadaveric allografts in the management of patients with bone tumors of the extremities. Orthop Clin North Am. 1987;18:275
-
.
Intertransverse process fusion with aid of chemosterilized autolyzed antigen-extracted allogeneic (AAA) bone.
Clin Orthop. 1981;154:97
- . The influence of surface chemistry on implant interface histology: a theoretical basis for implant material selection. J Biomed Mater Res. 1976;10:161
-
In: Toxicity of ceramics.
Williams DF editors.
The fundamental aspect of biocompatibility. Boca Raton: CRC Press,; 1981;p. 87
- . The influence of calcium phosphate biomaterials on human bone cell activities: an in vitro approach. J Biomed Mater Res. 1990;24:165
-
.
Periprosthetic osteolysis in total hip arthroplasty: the role of particulate wear debris.
J Bone Joint Surg Am. 1995;77:1448
-
.
Growth factors: a practical approach.
In:
McKay I, Leigh I editor.
Growth factors: a practical approach. Oxford: Oxford University Press,; 1993;p. 95
- The effect of sintered β-dicalcium pyrophosphate particle size on newborn Wistar rats osteoblasts. Artif Organs. 1999;23:331
- . Growth of osteoblasts on porous calcium phosphate ceramic: an in vitro model for biocompatibility study. Biomaterials. 1989;10:63
- . Studies on the mechanism of cell damage by finely ground hydroxyapatite particles in vitro. Clin Mater. 1991;7:241
- . Prostaglandin E2 causes a transient inhibition of mineral mobilization, matrix degradation, and lysosomal enzyme release from mouse calvarial bones in vitro. Calcif Tissue Int. 1987;40:323
- . Prostaglandins: stimulation of bone resorption in tissue culture. Endocrinology. 1970;86:1436
- . Role of the osteoclast in prostaglandin E2-stimulated bone resorption: a correlative morphometric and biochemical analysis. Lab Invest. 1980;42:290
- Tumor necrosis factor-alpha (cachectin) stimulates bone resorption in mouse calvaria via a prostaglandin-mediated mechanism. Endocrinology. 1987;120:2029
- . Bone resorption in vitro and in vivo in PGE-treated mice. Proc Soc Exp Biol Med. 1977;156:373
- Prostaglandin E2 administered by subcutaneous pellets causes local inflammation and systemic bone loss: a model for inflammation-induced bone disease. J Bone Miner Res. 1993;8:625
- . Inhibition of osteoclastic motility by prostaglandins I2, E1, E2 and 6-oxo-E1. J Pathol. 1983;139:383
- . The effect of calcium-regulating hormones and prostaglandins on bone resorption by osteoclasts disaggregated from neonatal rabbit bones. Endocrinology. 1985;116:234
- . Effect of arachidonic acid metabolites on bone resorption by isolated rat osteoclasts. J Bone Miner Res. 1989;4:209
- . Effect of prostaglendins E1, E2, F2α on osteoclast formation in mouse bone marrow cultures. J Bone Miner Res. 1991;6:157
-
.
Prostaglandin E2 initially inhibits and then stimulates bone resorption in isolated rabbit osteoclast cultures.
J Bone Miner Res. 1989;7:255
- . Prostaglandin E2 promotes osteoclast formation in murine hematopoietic cultures through an action on hematopoietic cells. J Bone Miner Res. 1992;7:555
- Inhibitory and stimulatory effects of prostaglandins on osteoclast differentiation. Calcif Tissue Int. 1997;60:63
- . Minireview: the OPG/RANKL/RANK system. Endocrinology. 2001;142:5050
- . Osteoprotegerin is produced when prostaglandin synthesis is inhibited causing osteoclasts to detach from the surface of mouse parietal bone and attach to the endocranial membrane. Bone. 2001;28:208
- Regulation of osteoclast differentiation by fibroblast growth factor 2: stimulation of receptor activator of nuclear factor kappaB ligand/osteoclast differentiation factor expression in osteoblasts and inhibition of macrophage colony-stimulating factor function in osteoclast precursors. J Bone Miner Res. 2001;16:2074
☆ Funds were received from the National Science Council, ROC, in support of the research material described in this study.
☆☆ Reprint requests: Feng-Huei Lin, PhD, Institute of Biomedical Engineering, National Taiwan University, No 1, Jen-Ai Road, Taipei, Taiwan, ROC.
★ 0883-5403/03/1803-0018$30.00/0
PII: S0883-5403(02)06255-1
doi: 10.1054/arth.2003.50054
© 2003 Elsevier Inc. All rights reserved.
« Previous
Next »
The Journal of Arthroplasty
Volume 18, Issue 3
, Pages 352-360
, April 2003
